Clinical Trials Directory

Trials / Completed

CompletedNCT01634035

Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients

Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients.

Status
Completed
Phase
Study type
Observational
Enrollment
159 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators are studying the correlation between Hba1c and the mean plasma glucose in diabetic hemodialysis patients.We are reviewing if HbA1c is a good clinical tool to assess glycemic control over a 3 months duration in hemodialysis patients

Detailed description

The Hb turnover in hemodialysis population is higher than the general population leading to a general believe that HbA1c tend to underestimate mean plasma glucose. The investigators are trying to define the correlation between mean plasma glucose and HbA1c in the hemodialysis population and trying to study the factors that could affect this correlation (dose of erythropoetin, ret count..) We are trying to see if HbA1c is a better tool to assess glycemic control over 1 month than glycemic control over 3 month. This clinicaly will translate in obtaining HbA1c more frequently in hemodialysis patients to assess their glycemic control.

Conditions

Timeline

Start date
2009-03-01
Primary completion
2009-05-01
Completion
2009-05-01
First posted
2012-07-06
Last updated
2012-07-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01634035. Inclusion in this directory is not an endorsement.

Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients (NCT01634035) · Clinical Trials Directory